Mersana Therapeutics (MRSN) Q4 2025 Earnings

14NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-4.87
-3.28
-1.7
-0.11

Details

Expected EPS
-1.1308
Actual EPS
-1.51
Surprise EPS
-0.38
Surprise Percent
+33.53%

Description

Mersana Therapeutics (MRSN) has reported earnings of -1.51 per share for Q4 2025.

0 Comments

Share your thoughts